Helen J. Ross
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology top 10%
- Surgery top 10%
- Immunology top 10%
- Co-authors
- Ernest M. WrightBruce R. StevensAmanda ClarkeElizabeth HansonHong‐Ming HuColeman K. ObasajuRobert A. FiglinTarsem Moudgil
- Topics
- Lung Cancer Treatments and Mutations (43 papers)Lung Cancer Research Studies (34 papers)Lung Cancer Diagnosis and Treatment (27 papers)
- Partner nations
- United StatesUnited KingdomIreland
In The Last Decade
Helen J. Ross
117 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 147
- Oncology 1.4k
- Pulmonary and Respiratory Medicine 1.3k
- Molecular Biology 772
- Surgery 440
- Immunology 334
Countries citing papers authored by Helen J. Ross
This map shows the geographic impact of Helen J. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen J. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen J. Ross more than expected).
Fields of papers citing papers by Helen J. Ross
This network shows the impact of papers produced by Helen J. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen J. Ross. The network helps show where Helen J. Ross may publish in the future.
Co-authorship network of co-authors of Helen J. Ross
This figure shows the co-authorship network connecting the top 25 collaborators of Helen J. Ross. A scholar is included among the top collaborators of Helen J. Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen J. Ross. Helen J. Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 23 | |
| 4 | 3 | |
| 5 | 14 | |
| 6 | 40 | |
| 7 | 9 | |
| 8 | 0 | |
| 9 | 120 | |
| 10 | 29 | |
| 11 | 36 | |
| 12 | 14 | |
| 13 | Performans Statusu 2 Olan ve İleri Evre Küçük Hücreli Dışı Akciğer Kanseri Olgularında Kombinasyona Karşı Tek Ajan Kemoterapisi İki Büyük Randomize Klinik Çalışma Çerçevesinde Prognostik Faktörler ve Tedavi Seçimi | 1 |
| 14 | 2 | |
| 15 | 160 | |
| 16 | 50 | |
| 17 | 58 | |
| 18 | The BH3-only proapoptotic protein Bim directly links the microtubule poison Paclitaxel to mitochondrial damage and apoptosis | 2 |
| 19 | 170 | |
| 20 | Cyclosporin A enhances paclitaxel toxicity against leukemia and respiratory epithelial cancers. | 12 |
About Helen J. Ross
Helen J. Ross is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Research and Theory, having authored 121 papers that have together received 3.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (43 papers), Lung Cancer Research Studies (34 papers) and Lung Cancer Diagnosis and Treatment (27 papers). The work is most often cited by research in Research and Theory (60 citations), Oncology (1.4k citations) and Pulmonary and Respiratory Medicine (1.3k citations). Helen J. Ross has collaborated with scholars based in United States, United Kingdom and Ireland. Frequent co-authors include Ernest M. Wright, Bruce R. Stevens, Amanda Clarke, Elizabeth Hanson, Hong‐Ming Hu, Coleman K. Obasaju, Robert A. Figlin, Tarsem Moudgil, Pasi A. Jänne and Chandra P. Belani. Their work appears in journals such as Journal of Clinical Oncology, Annals of Internal Medicine and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.